1. Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies
   Ana Quiles-Jiménez et al, 2022, Stroke CrossRef
2. Phospholamban R14del disease: The past, the present and the future
   Elizabeth Vafiadaki et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
3. ALKBH5 inhibitors as a potential treatment strategy in heart failure—inferences from gene expression profiling
   Sumra Komal et al, 2023, Frontiers in Cardiovascular Medicine CrossRef
4. Epitranscriptomics as a New Layer of Regulation of Gene Expression in Skeletal Muscle: Known Functions and Future Perspectives
   Carol Imbriano et al, 2023, International Journal of Molecular Sciences CrossRef
5. RNA modification m 6 Am: the role in cardiac biology
   Daniel Benak et al, 2023, Epigenetics CrossRef
6. Epitranscriptomic regulations in the heart
   D Benak et al, 2024, Physiological Research CrossRef
7. Potential usages of A-to-I RNA editing patterns as diagnostic biomarkers
   David Rodriguez Morales et al, 2023, American Journal of Physiology-Cell Physiology CrossRef
8. Deciphering impact of single nucleotide polymorphisms on cotranscriptional modification in CCM gene mRNAs
   Concetta Scimone et al, 2022, American Journal of Physiology-Cell Physiology CrossRef
9. Epigenetics of Early Cardiometabolic Disease: Mechanisms and Precision Medicine
   Andrea A. Baccarelli et al, 2023, Circulation Research CrossRef
10. Exercise Mitigates Endothelial Pyroptosis and Atherosclerosis by Downregulating NEAT1 Through N6-Methyladenosine Modifications
    Qingyuan Yang et al, 2023, Arteriosclerosis, Thrombosis, and Vascular Biology CrossRef